Symbols / MDGL Stock $529.14 +0.27% Madrigal Pharmaceuticals, Inc.

Healthcare • Biotechnology • United States • NMS
MDGL (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Stock Fundamentals
Scroll to Statements
Market Cap 12.20B Enterprise Value — Income — Sales — Book/sh — Cash/sh —
Dividend Yield — Payout — Employees — IPO — P/E — Forward P/E —
PEG — P/S — P/B — P/C — EV/EBITDA — EV/Sales —
Quick Ratio — Current Ratio — Debt/Eq — LT Debt/Eq — EPS (ttm) — EPS next Y —
EPS Growth — Revenue Growth — Earnings — ROA — ROE — ROIC —
Gross Margin — Oper. Margin — Profit Margin — Shs Outstand — Shs Float — Short Float —
Short Ratio — Short Interest — 52W High — 52W Low — Beta — Avg Volume —
Volume — Target Price — Recom — Prev Close $527.69 Price $529.14 Change 0.27%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest MDGL news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
958.40
+432.05%
180.13
0.00
0.00
Operating Revenue
958.40
+432.05%
180.13
0.00
0.00
Cost Of Revenue
56.15
+800.82%
6.23
0.00
0.00
Reconciled Cost Of Revenue
56.15
+800.82%
6.23
0.00
0.00
Gross Profit
902.25
+418.84%
173.90
0.00
0.00
Operating Expense
1,202.35
+78.98%
671.77
+76.55%
380.50
+29.61%
293.57
Research And Development
388.52
+64.13%
236.72
-13.08%
272.35
+10.96%
245.44
Selling General And Administration
813.83
+87.06%
435.06
+302.29%
108.15
+124.70%
48.13
General And Administrative Expense
—
—
108.15
+124.70%
48.13
Other Gand A
—
—
108.15
+124.70%
48.13
Total Expenses
1,258.50
+85.62%
678.01
+78.19%
380.50
+29.61%
293.57
Operating Income
-300.10
+39.72%
-497.88
-30.85%
-380.50
-29.61%
-293.57
Total Operating Income As Reported
-300.10
+39.72%
-497.88
-30.85%
-380.50
-29.61%
-293.57
EBITDA
-264.47
+41.25%
-450.12
-24.90%
-360.39
-23.88%
-290.92
Normalized EBITDA
-261.69
+41.86%
-450.12
-24.90%
-360.39
-23.88%
-290.92
Reconciled Depreciation
1.51
+37.41%
1.10
+107.97%
0.53
+12.85%
0.47
EBIT
-265.98
+41.05%
-451.22
-25.02%
-360.92
-23.86%
-291.39
Total Unusual Items
-2.78
0.00
0.00
—
Total Unusual Items Excluding Goodwill
-2.78
0.00
0.00
—
Special Income Charges
-2.78
0.00
0.00
—
Other Special Charges
2.78
—
—
—
Net Income
-288.28
+38.12%
-465.89
-24.69%
-373.63
-26.50%
-295.35
Pretax Income
-288.28
+38.12%
-465.89
-24.69%
-373.63
-26.50%
-295.35
Net Non Operating Interest Income Expense
15.05
-52.93%
31.98
+365.82%
6.87
+485.95%
-1.78
Interest Expense Non Operating
22.31
+52.06%
14.67
+15.41%
12.71
+220.69%
3.96
Net Interest Income
15.05
-52.93%
31.98
+365.82%
6.87
+485.95%
-1.78
Interest Expense
22.31
+52.06%
14.67
+15.41%
12.71
+220.69%
3.96
Interest Income Non Operating
37.36
-19.91%
46.65
+138.30%
19.58
+796.02%
2.19
Interest Income
37.36
-19.91%
46.65
+138.30%
19.58
+796.02%
2.19
Other Income Expense
-3.24
—
—
—
Other Non Operating Income Expenses
-0.46
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-288.28
+38.12%
-465.89
-24.69%
-373.63
-26.50%
-295.35
Net Income From Continuing Operation Net Minority Interest
-288.28
+38.12%
-465.89
-24.69%
-373.63
-26.50%
-295.35
Net Income From Continuing And Discontinued Operation
-288.28
+38.12%
-465.89
-24.69%
-373.63
-26.50%
-295.35
Normalized Income
-285.50
+38.72%
-465.89
-24.69%
-373.63
-26.50%
-295.35
Net Income Common Stockholders
-288.28
+38.12%
-465.89
-24.69%
-373.63
-26.50%
-295.35
Diluted EPS
-12.85
+41.32%
-21.90
-9.55%
-19.99
-16.02%
-17.23
Basic EPS
-12.85
+41.32%
-21.90
-9.55%
-19.99
-16.02%
-17.23
Basic Average Shares
22.43
+5.46%
21.27
+13.83%
18.69
+9.05%
17.14
Diluted Average Shares
22.43
+5.46%
21.27
+13.83%
18.69
+9.05%
17.14
Diluted NI Availto Com Stockholders
-288.28
+38.12%
-465.89
-24.69%
-373.63
-26.50%
-295.35
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,259.59
+20.85%
1,042.25
+62.71%
640.55
+76.67%
362.57
Current Assets
1,245.77
+20.61%
1,032.93
+62.08%
637.28
+76.35%
361.37
Cash Cash Equivalents And Short Term Investments
983.56
+6.19%
926.25
+46.07%
634.13
+76.75%
358.77
Cash And Cash Equivalents
198.69
+98.66%
100.02
+0.10%
99.92
-69.86%
331.55
Cash Equivalents
—
—
97.19
-69.29%
316.45
Cash Financial
—
—
2.73
-81.93%
15.10
Other Short Term Investments
784.87
-5.01%
826.23
+54.66%
534.22
+1862.23%
27.23
Receivables
134.48
+149.85%
53.82
0.00
—
Accounts Receivable
134.48
+149.85%
53.82
0.00
—
Inventory
74.84
+119.68%
34.07
0.00
—
Raw Materials
0.00
0.00
0.00
—
Work In Process
67.63
+129.01%
29.53
0.00
—
Finished Goods
7.21
+58.94%
4.54
0.00
—
Prepaid Assets
—
—
—
—
Restricted Cash
5.09
+1.80%
5.00
0.00
—
Other Current Assets
47.80
+246.76%
13.79
+337.65%
3.15
+21.39%
2.60
Total Non Current Assets
13.82
+48.27%
9.32
+185.36%
3.27
+171.49%
1.20
Net PPE
6.44
+40.23%
4.59
+40.57%
3.27
+171.49%
1.20
Gross PPE
6.44
+40.23%
4.59
+40.57%
3.27
+171.49%
1.20
Other Properties
6.44
+40.23%
4.59
+40.57%
3.27
+171.49%
1.20
Goodwill And Other Intangible Assets
7.38
+56.08%
4.73
0.00
—
Total Liabilities Net Minority Interest
656.90
+128.20%
287.86
+22.38%
235.21
+42.40%
165.18
Current Liabilities
310.29
+83.30%
169.28
+42.79%
118.55
+2.29%
115.89
Payables And Accrued Expenses
240.06
+80.04%
133.34
+32.03%
100.99
+0.56%
100.43
Payables
48.88
+12.11%
43.60
+55.48%
28.04
+17.67%
23.83
Accounts Payable
48.88
+12.11%
43.60
+55.48%
28.04
+17.67%
23.83
Current Accrued Expenses
191.18
+113.04%
89.74
+23.01%
72.95
-4.76%
76.60
Pensionand Other Post Retirement Benefit Plans Current
69.21
+97.99%
34.96
+105.27%
17.03
+14.57%
14.86
Current Debt And Capital Lease Obligation
1.02
+3.56%
0.98
+86.53%
0.53
-12.46%
0.60
Current Capital Lease Obligation
1.02
+3.56%
0.98
+86.53%
0.53
-12.46%
0.60
Total Non Current Liabilities Net Minority Interest
346.61
+192.28%
118.59
+1.65%
116.67
+136.70%
49.29
Long Term Debt And Capital Lease Obligation
346.61
+192.28%
118.59
+1.65%
116.67
+136.70%
49.29
Long Term Debt
339.88
+189.09%
117.57
+1.81%
115.48
+134.29%
49.29
Long Term Capital Lease Obligation
6.73
+561.20%
1.02
-14.17%
1.19
0.00
Stockholders Equity
602.69
-20.11%
754.38
+86.11%
405.33
+105.35%
197.39
Common Stock Equity
602.69
-20.11%
754.38
+86.11%
405.33
+105.35%
197.39
Capital Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Common Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
22.84
+3.81%
22.00
+10.71%
19.88
+9.79%
18.10
Ordinary Shares Number
22.84
+3.81%
22.00
+10.71%
19.88
+9.79%
18.10
Additional Paid In Capital
2,692.28
+5.33%
2,556.09
+46.80%
1,741.15
+50.09%
1,160.08
Retained Earnings
-2,090.47
-16.00%
-1,802.18
-34.86%
-1,336.29
-38.81%
-962.66
Gains Losses Not Affecting Retained Earnings
0.87
+86.54%
0.47
+0.00%
0.47
+1562.50%
-0.03
Other Equity Adjustments
0.87
+86.54%
0.47
+0.00%
0.47
+1562.50%
-0.03
Total Equity Gross Minority Interest
602.69
-20.11%
754.38
+86.11%
405.33
+105.35%
197.39
Total Capitalization
942.57
+8.10%
871.95
+67.42%
520.81
+111.13%
246.68
Working Capital
935.48
+8.32%
863.65
+66.49%
518.73
+111.32%
245.47
Invested Capital
942.57
+8.10%
871.95
+67.42%
520.81
+111.13%
246.68
Total Debt
347.63
+190.73%
119.57
+2.03%
117.19
+134.90%
49.89
Net Debt
141.19
+704.49%
17.55
+12.75%
15.56
—
Capital Lease Obligations
7.75
+287.26%
2.00
+16.81%
1.71
+184.55%
0.60
Net Tangible Assets
595.31
-20.59%
749.65
+84.95%
405.33
+105.35%
197.39
Tangible Book Value
595.31
-20.59%
749.65
+84.95%
405.33
+105.35%
197.39
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-189.55
+58.39%
-455.57
-40.51%
-324.23
-44.19%
-224.86
Cash Flow From Continuing Operating Activities
-189.55
+58.39%
-455.57
-40.51%
-324.23
-44.19%
-224.86
Net Income From Continuing Operations
-288.28
+38.12%
-465.89
-24.69%
-373.63
-26.50%
-295.35
Depreciation Amortization Depletion
1.51
+37.41%
1.10
+107.97%
0.53
+12.85%
0.47
Depreciation And Amortization
1.51
+37.41%
1.10
+107.97%
0.53
+12.85%
0.47
Other Non Cash Items
4.81
+185.02%
1.69
-30.03%
2.41
+202.89%
0.80
Stock Based Compensation
98.13
+22.85%
79.88
+60.61%
49.73
+57.26%
31.62
Operating Gains Losses
2.78
—
—
—
Change In Working Capital
-8.50
+88.25%
-72.34
-2108.33%
-3.28
-108.71%
37.60
Change In Receivables
-80.65
-49.85%
-53.82
0.00
0.00
Changes In Account Receivables
-80.65
-49.85%
-53.82
0.00
0.00
Change In Inventory
-36.98
-8.54%
-34.07
0.00
0.00
Change In Prepaid Assets
-34.02
-219.84%
-10.64
-1816.40%
-0.56
+55.85%
-1.26
Change In Payables And Accrued Expense
143.15
+446.78%
26.18
+1062.18%
-2.72
-107.00%
38.86
Change In Accrued Expense
137.87
+1197.87%
10.62
+253.27%
-6.93
-119.04%
36.41
Change In Payable
5.28
-66.07%
15.56
+269.55%
4.21
+71.77%
2.45
Change In Account Payable
5.28
-66.07%
15.56
+269.55%
4.21
+71.77%
2.45
Investing Cash Flow
32.32
+111.78%
-274.39
+45.40%
-502.52
-343.13%
206.69
Cash Flow From Continuing Investing Activities
32.32
+111.78%
-274.39
+45.40%
-502.52
-343.13%
206.69
Net PPE Purchase And Sale
-0.47
+68.06%
-1.46
+1.15%
-1.48
-581.57%
-0.22
Purchase Of PPE
-0.47
+68.06%
-1.46
+1.15%
-1.48
-581.57%
-0.22
Capital Expenditure
-3.47
+46.35%
-6.46
-336.92%
-1.48
-581.57%
-0.22
Net Investment Purchase And Sale
35.79
+113.36%
-267.92
+46.53%
-501.04
-342.16%
206.90
Purchase Of Investment
-1,047.51
+7.40%
-1,131.21
-35.56%
-834.44
-481.58%
-143.48
Sale Of Investment
1,083.30
+25.49%
863.28
+158.93%
333.40
-4.85%
350.38
Net Intangibles Purchase And Sale
-3.00
+40.00%
-5.00
0.00
0.00
Purchase Of Intangibles
-3.00
+40.00%
-5.00
0.00
0.00
Financing Cash Flow
255.98
-65.18%
735.06
+23.52%
595.12
+89.86%
313.45
Cash Flow From Continuing Financing Activities
255.98
-65.18%
735.06
+23.52%
595.12
+89.86%
313.45
Net Issuance Payments Of Debt
228.34
0.00
-100.00%
65.00
+30.00%
50.00
Issuance Of Debt
350.00
0.00
-100.00%
65.00
+30.00%
50.00
Repayment Of Debt
-121.66
0.00
0.00
—
Long Term Debt Issuance
350.00
0.00
-100.00%
65.00
+30.00%
50.00
Long Term Debt Payments
-121.66
0.00
0.00
—
Net Long Term Debt Issuance
228.34
0.00
-100.00%
65.00
+30.00%
50.00
Net Common Stock Issuance
0.00
-100.00%
397.49
+52.77%
260.19
+1.88%
255.38
Proceeds From Stock Option Exercised
38.05
-88.73%
337.57
+24.89%
270.29
+2918.34%
8.96
Net Other Financing Charges
-10.41
—
-0.36
+59.03%
-0.89
Changes In Cash
98.75
+1834.78%
5.10
+102.20%
-231.63
-178.45%
295.28
Effect Of Exchange Rate Changes
0.01
0.00
0.00
—
Beginning Cash Position
105.02
+5.11%
99.92
-69.86%
331.55
+814.14%
36.27
End Cash Position
203.78
+94.04%
105.02
+5.11%
99.92
-69.86%
331.55
Free Cash Flow
-193.02
+58.22%
-462.03
-41.85%
-325.71
-44.71%
-225.07
Change In Interest Payable
5.97
+124.78%
-24.09
-342.06%
-5.45
-181566.67%
-0.00
Common Stock Issuance
0.00
-100.00%
397.49
+52.77%
260.19
+1.88%
255.38
Issuance Of Capital Stock
0.00
-100.00%
397.49
+52.77%
260.19
+1.88%
255.38
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category